Report cover image

Global Bird Flu Treatment Market Size study, by Treatment Type, Route of Administration, Dosage Form, Intended Use, Patient Population and Regional Forecasts 2022-2032

Publisher Bizwit Research & Consulting
Published May 30, 2025
Length 285 Pages
SKU # BIZW20056991

Description

The Global Bird Flu Treatment Market is valued approximately at USD 1.75 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.56% over the forecast period 2024-2032. As highly pathogenic avian influenza viruses continue to pose persistent threats to global health, the need for effective bird flu treatments has become increasingly urgent. These viral outbreaks, often characterized by their rapid transmission and high mortality rates, necessitate the development and deployment of tailored antiviral strategies. Bird flu treatment encompasses a multidisciplinary framework, including antiviral medications, supportive care protocols, and prophylactic measures designed to curb infection spread and improve clinical outcomes. The landscape is evolving as pharmaceutical innovation aligns with governmental preparedness initiatives to tackle zoonotic spillovers. The growing convergence of virology research and pharmacotherapeutic advancements is catalyzing the commercialization of next-generation solutions targeting avian influenza strains.

The global surge in bird flu cases, particularly in densely populated poultry-farming regions and migratory bird corridors, is propelling the demand for robust treatment regimens. With pandemic preparedness remaining at the forefront of public health policy, agencies are accelerating investments in novel treatment options and post-exposure prophylaxis. For instance, increased stockpiling of neuraminidase inhibitors like oseltamivir, alongside investments in inhalable antiviral therapies, underscores the proactive stance taken by healthcare systems worldwide. Simultaneously, high-risk populations such as frontline workers, immunocompromised patients, and poultry industry personnel are being prioritized for pre-emptive treatment strategies. The anticipated launch of oral antiviral compounds with improved bioavailability and fewer side effects also presents a pivotal growth opportunity in the bird flu treatment market.

Despite the promising trajectory, the market does grapple with inherent challenges. The rapid mutational dynamics of avian influenza viruses often undermine the efficacy of existing drug therapies, necessitating constant innovation and surveillance. Moreover, limited healthcare access in developing regions impedes timely diagnosis and treatment, further complicating containment efforts. The relatively small patient pool during inter-epidemic periods also deters certain pharmaceutical players from investing in long-term R&D. Nonetheless, increasing government support, global disease monitoring networks, and public-private collaborations are actively working to overcome these barriers through knowledge sharing and funding incentives.

Innovation is not confined to drug formulations alone; the industry is also exploring advanced delivery systems and personalized treatment pathways. Intravenous solutions, once considered the gold standard, are now being augmented by inhalational and oral delivery routes that offer convenience and speed in emergency settings. The development of pediatric formulations and targeted solutions for geriatric and immunocompromised populations illustrates the market’s pivot toward inclusivity and tailored therapeutics. Moreover, the emergence of AI-driven predictive models is enhancing epidemic preparedness by identifying optimal dosage regimens based on viral load, patient history, and regional strain variations, leading to more precise and effective interventions.

Geographically, North America dominates the bird flu treatment landscape, largely due to advanced healthcare infrastructure, rigorous disease surveillance programs, and established pharmaceutical ecosystems. Europe follows closely, with strong R&D capacities and government-backed health initiatives across countries like Germany, France, and the UK. The Asia Pacific region, however, is poised to witness the fastest growth over the forecast period. Rising poultry production, frequent zoonotic spillovers, and increasing healthcare expenditures are driving the region’s rapid adoption of avian flu therapeutics. Countries such as China, India, and South Korea are intensifying efforts through vaccine development, drug importation, and regional containment strategies.

Major market player included in this report are:
• GlaxoSmithKline plc
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Daiichi Sankyo Company, Limited
• Cipla Inc.
• Abbott Laboratories
• Sanofi S.A.
• Dr. Reddy's Laboratories Ltd.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• BioCryst Pharmaceuticals, Inc.
• Johnson & Johnson Services, Inc.
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• Emergent BioSolutions Inc.

The detailed segments and sub-segmens of the market are explained below:

By Treatment Type
• Antiviral Medications
• Supportive Care
• Prophylactic Measures

By Route of Administration
• Oral
• Intravenous
• Inhalational

By Dosage Form
• Tablets
• Capsules
• Solutions
• Injections

By Intended Use
• Initial Treatment
• Prevention
• Post-Exposure Prophylaxis

By Patient Population
• Adults
• Pediatric
• High-Risk Individuals

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Bird Flu Treatment Market Executive Summary
1.1. Global Bird Flu Treatment Market Size & Forecast (2022 – 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Treatment Type
1.3.2. By Route of Administration
1.3.3. By Dosage Form
1.3.4. By Intended Use
1.3.5. By Patient Population
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Bird Flu Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Bird Flu Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Escalating Prevalence of Avian Influenza Outbreaks
3.1.2. Increasing Government Investments in Pandemic Preparedness
3.1.3. Advancements in Antiviral Drug Development & Delivery
3.2. Market Challenges
3.2.1. Rapid Viral Mutation and Drug Resistance
3.2.2. Inadequate Healthcare Access in Emerging Regions
3.3. Market Opportunities
3.3.1. Growth of AI-Driven Predictive Treatment Models
3.3.2. Expansion of Oral & Inhalational Therapies
3.3.3. Rising Demand for Prophylactic Measures
Chapter 4. Global Bird Flu Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Bird Flu Treatment Market Size & Forecasts by Treatment Type 2022 – 2032
5.1. Segment Dashboard
5.2. Global Bird Flu Treatment Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Antiviral Medications
5.2.2. Supportive Care
5.2.3. Prophylactic Measures
Chapter 6. Global Bird Flu Treatment Market Size & Forecasts by Route of Administration 2022 – 2032
6.1. Segment Dashboard
6.2. Global Bird Flu Treatment Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Oral
6.2.2. Intravenous
6.2.3. Inhalational
Chapter 7. Global Bird Flu Treatment Market Size & Forecasts by Dosage Form 2022 – 2032
7.1. Segment Dashboard
7.2. Global Bird Flu Treatment Market: Dosage Form Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Tablets
7.2.2. Capsules
7.2.3. Solutions
7.2.4. Injections
Chapter 8. Global Bird Flu Treatment Market Size & Forecasts by Intended Use 2022 – 2032
8.1. Segment Dashboard
8.2. Global Bird Flu Treatment Market: Intended Use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Initial Treatment
8.2.2. Prevention
8.2.3. Post-Exposure Prophylaxis
Chapter 9. Global Bird Flu Treatment Market Size & Forecasts by Patient Population 2022 – 2032
9.1. Segment Dashboard
9.2. Global Bird Flu Treatment Market: Patient Population Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
9.2.1. Adults
9.2.2. Pediatric
9.2.3. High-Risk Individuals
Chapter 10. Global Bird Flu Treatment Market Size & Forecasts by Region 2022 – 2032
10.1. North America Bird Flu Treatment Market
10.1.1. U.S. Bird Flu Treatment Market
10.1.1.1. Treatment Type breakdown size & forecasts, 2022 – 2032
10.1.1.2. Route of Administration breakdown size & forecasts, 2022 – 2032
10.1.1.3. Dosage Form breakdown size & forecasts, 2022 – 2032
10.1.1.4. Intended Use breakdown size & forecasts, 2022 – 2032
10.1.1.5. Patient Population breakdown size & forecasts, 2022 – 2032
10.1.2. Canada Bird Flu Treatment Market
10.1.2.1. Treatment Type breakdown size & forecasts, 2022 – 2032
10.1.2.2. …
10.2. Europe Bird Flu Treatment Market
10.2.1. UK Bird Flu Treatment Market
10.2.1.1. Treatment Type breakdown size & forecasts, 2022 – 2032
10.2.1.2. …
10.2.2. Germany
10.2.3. France
10.2.4. Spain
10.2.5. Italy
10.2.6. Rest of Europe
10.3. Asia-Pacific Bird Flu Treatment Market
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia Pacific
10.4. Latin America Bird Flu Treatment Market
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Middle East & Africa Bird Flu Treatment Market
10.5.1. Saudi Arabia
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. GlaxoSmithKline plc
11.1.2. F. Hoffmann-La Roche Ltd.
11.1.3. Novartis AG
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. GlaxoSmithKline plc
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. F. Hoffmann-La Roche Ltd.
11.3.3. Novartis AG
11.3.4. Daiichi Sankyo Company, Limited
11.3.5. Cipla Inc.
11.3.6. Abbott Laboratories
11.3.7. Sanofi S.A.
11.3.8. Dr. Reddy’s Laboratories Ltd.
11.3.9. Teva Pharmaceutical Industries Ltd.
11.3.10. Mylan N.V.
11.3.11. BioCryst Pharmaceuticals, Inc.
11.3.12. Johnson & Johnson Services, Inc.
11.3.13. Pfizer Inc.
11.3.14. Takeda Pharmaceutical Company Limited
11.3.15. Emergent BioSolutions Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
List of Tables
TABLE 1. Global Bird Flu Treatment market, report scope
TABLE 2. Global Bird Flu Treatment market estimates & forecasts by Region 2022 – 2032 (USD Million/Billion)
TABLE 3. Global Bird Flu Treatment market estimates & forecasts by Treatment Type 2022 – 2032 (USD Million/Billion)
TABLE 4. Global Bird Flu Treatment market estimates & forecasts by Route of Administration 2022 – 2032 (USD Million/Billion)
TABLE 5. Global Bird Flu Treatment market estimates & forecasts by Dosage Form 2022 – 2032 (USD Million/Billion)
TABLE 6. Global Bird Flu Treatment market estimates & forecasts by Intended Use 2022 – 2032 (USD Million/Billion)
TABLE 7. Global Bird Flu Treatment market estimates & forecasts by Patient Population 2022 – 2032 (USD Million/Billion)
TABLE 8. Global Bird Flu Treatment market by segment, estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 9. Global Bird Flu Treatment market by region, estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 10. U.S. Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 11. U.S. Bird Flu Treatment market estimates & forecasts by segment, 2022 – 2032 (USD Million/Billion)
TABLE 12. Canada Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 13. Canada Bird Flu Treatment market by segment, 2022 – 2032 (USD Million/Billion)
TABLE 14. Rest of Europe Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 15. China Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 16. India Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 17. Brazil Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 18. Mexico Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 19. Saudi Arabia Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
TABLE 20. South Africa Bird Flu Treatment market estimates & forecasts, 2022 – 2032 (USD Million/Billion)
List of Figures
FIGURE 1. Global Bird Flu Treatment market, research methodology
FIGURE 2. Global Bird Flu Treatment market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods
FIGURE 4. Global Bird Flu Treatment market, key trends 2023
FIGURE 5. Global Bird Flu Treatment market, growth prospects 2022 – 2032
FIGURE 6. Global Bird Flu Treatment market, Porter’s 5 Force model
FIGURE 7. Global Bird Flu Treatment market, PESTEL analysis
FIGURE 8. Global Bird Flu Treatment market, value chain analysis
FIGURE 9. Global Bird Flu Treatment market by segment, 2022 & 2032 (USD Million/Billion)
FIGURE 10. Global Bird Flu Treatment market by segment, 2022 & 2032 (USD Million/Billion)
FIGURE 11. Global Bird Flu Treatment market by segment, 2022 & 2032 (USD Million/Billion)
FIGURE 12. Global Bird Flu Treatment market by segment, 2022 & 2032 (USD Million/Billion)
FIGURE 13. Global Bird Flu Treatment market, regional snapshot 2022 & 2032
FIGURE 14. North America Bird Flu Treatment market 2022 & 2032 (USD Million/Billion)
FIGURE 15. Europe Bird Flu Treatment market 2022 & 2032 (USD Million/Billion)
FIGURE 16. Asia-Pacific Bird Flu Treatment market 2022 & 2032 (USD Million/Billion)
FIGURE 17. Latin America Bird Flu Treatment market 2022 & 2032 (USD Million/Billion)
FIGURE 18. Middle East & Africa Bird Flu Treatment market 2022 & 2032 (USD Million/Billion)
FIGURE 19. Global Bird Flu Treatment market, company market share analysis (2023)
FIGURE 20. Global Bird Flu Treatment market, country-level concentration heatmap

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us